DIABETIC MACULAR EDEMA (DME)
Clinical trials for DIABETIC MACULAR EDEMA (DME) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC MACULAR EDEMA (DME) trials appear
Sign up with your email to follow new studies for DIABETIC MACULAR EDEMA (DME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Beovu shows Real-World promise for two common eye diseases
Disease control CompletedThis study looked at how well the eye medication Beovu (brolucizumab) works in everyday medical practice for people with wet age-related macular degeneration (AMD) or diabetic macular edema (DME). Researchers observed 572 patients who were already prescribed Beovu by their doctor…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New eye drug OLN324 shows promise in early trial for two blinding diseases
Disease control CompletedThis early-phase study tested a new eye injection called OLN324 in 164 adults with either wet age-related macular degeneration (AMD) or diabetic macular edema (DME). The main goal was to check safety and how the drug moves through the body, while also looking for early signs it m…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
New eye drug shows promise for blinding diseases
Disease control CompletedThis study tested a new eye injection called EYE103 in people with diabetic macular edema (DME) or wet age-related macular degeneration (NVAMD). The goal was to check safety and see if it helps improve vision. About 33 people took part, and the study looked at side effects and vi…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
Eye injection study reveals which patients feel the most strain
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated eye injections for three different eye diseases: wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Researchers interviewed 393 patients about their treatment experience, …
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC